After 8 weeks of follow-up after IMT treatment, Hvas et al. found that one patient had small bowel bacterial overgrowth after primary IMT and that there were no statistically significant changes in patients' body weight, plasma albumin, or haemoglobin [43]. The gene discussed is ALB; the disease is inflammatory myofibroblastic tumor.